{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005388,73,MONDO:0005388,35,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005388","source":"MONDO:0005388|primary biliary cholangitis","targets":["NCT00108355|Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00179413|Study of Long-term Peg Intron vs. Colchicine in Non-responders.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00287664|Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin|SUSPENDED|PHASE4|INTERVENTIONAL","NCT00347009|Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00359853|Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00414713|Transfusion Requirements in Gastrointestinal (GI) Bleeding|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00450164|Secondary Prophylaxis After Variceal Bleeding in Non-Responders|COMPLETED|PHASE4|INTERVENTIONAL","NCT00494312|Safety Study of Pioglitazone Compared To Glyburide on Liver Function|COMPLETED|PHASE4|INTERVENTIONAL","NCT00513201|Lyspro Insulin vs Regular Insulin in Cirrhotic Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00534677|The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed|COMPLETED|PHASE4|INTERVENTIONAL","NCT00570622|Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00570973|Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00596414|Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT00741663|Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00760032|Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00761098|Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00906139|Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00921349|A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00965900|Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00966082|EBL Versus EBL and Propranolol for the Prevention of Variceal Rebleeding in Pts With Previous Variceal Treatment|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00966121|Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00968695|Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01292304|Tolvaptan for Ascites in Cirrhotic Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01510860|Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01530711|Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01686698|Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01744847|DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01820026|Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01842581|The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01847651|Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate|COMPLETED|PHASE4|INTERVENTIONAL","NCT01893541|PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?|COMPLETED|PHASE4|INTERVENTIONAL","NCT02034279|The INFECIR-2 Albumin Prevention Study|TERMINATED|PHASE4|INTERVENTIONAL","NCT02074280|Rifaximin Predicts the Complications of Decompensated Cirrhosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02078882|Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02190357|Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02238444|Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02247414|Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection|COMPLETED|PHASE4|INTERVENTIONAL","NCT02249741|Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation|COMPLETED|PHASE4|INTERVENTIONAL","NCT02304159|Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics|COMPLETED|PHASE4|INTERVENTIONAL","NCT02321202|Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT02344719|Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02344823|Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02401490|Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02533934|Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant|COMPLETED|PHASE4|INTERVENTIONAL","NCT02557360|Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02638415|The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02755701|The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02757170|Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02854371|Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI|COMPLETED|PHASE4|INTERVENTIONAL","NCT02907749|Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02925975|Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03023189|Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03087656|Antibiotics to Decrease Post ERCP Cholangitis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03091738|Ramelteon for Treatment of Insomnia in Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03176966|Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03345589|A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04074473|Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varices|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04376528|Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04617561|Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04618575|Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04645550|Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）|COMPLETED|PHASE4|INTERVENTIONAL","NCT04650243|Clinical Research of Tapering UDCA in PBC Patients With a Complete Response|RECRUITING|PHASE4|INTERVENTIONAL","NCT04893993|PBC Induced Fatigue Treated With Thiamine|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04933292|A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04976543|Safety of Anticoagulant Therapy After Endoscopic Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT05147090|Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT05467826|Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05724485|Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT05737030|Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT06021860|A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT06277882|Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis|RECRUITING|PHASE4|INTERVENTIONAL","NCT06371196|Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06594783|Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders|RECRUITING|PHASE4|INTERVENTIONAL","NCT06808074|A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis|RECRUITING|PHASE4|INTERVENTIONAL","NCT06881628|Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients|RECRUITING|PHASE4|INTERVENTIONAL","NCT07132515|Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC|RECRUITING|PHASE4|INTERVENTIONAL","NCT07322237|DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis|RECRUITING|PHASE4|INTERVENTIONAL","NCT00048724|Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00058890|Gabapentin to Treat Itch in Patients With Liver Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00076336|Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00115947|Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00124228|Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00151671|Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00162552|Clinical Trial of Pentoxifylline in Patient With Cirrhosis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00244569|Development of a Breath Test for Monitoring Patients With Liver Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00275652|A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00490620|Study of Combivir for Patients With Primary Biliary Cirrhosis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00493480|Danish Carvedilol Study in Portal Hypertension|COMPLETED|PHASE3|INTERVENTIONAL","NCT00502086|Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00742339|Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00742690|Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00746486|Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)|TERMINATED|PHASE3|INTERVENTIONAL","NCT00805805|Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00844402|Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00986817|Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin|COMPLETED|PHASE3|INTERVENTIONAL","NCT01037959|Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure|TERMINATED|PHASE3|INTERVENTIONAL","NCT01048788|A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg|COMPLETED|PHASE3|INTERVENTIONAL","NCT01050530|A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema|COMPLETED|PHASE3|INTERVENTIONAL","NCT01095185|Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding|COMPLETED|PHASE3|INTERVENTIONAL","NCT01114828|A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema|COMPLETED|PHASE3|INTERVENTIONAL"]}]}